Actively Recruiting
Observational Registry of Patient-Reported Outcomes After Middle Meningeal Artery Embolization for Migraine in Adults
Led by Cortex Neurovascular · Updated on 2026-09-23
50
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are collecting and analyzing patient-reported outcomes from adults with migraine who have undergone or plan to undergo middle meningeal artery MMA embolization. This observational registry focuses on changes in headache frequency, severity, medication use, migraine-related disability, quality of life, and any reported adverse events over time without affecting clinical care. The study is part of the EMBRACE research program conducted at a single site. MMA embolization is performed as part of routine clinical care using FDA-cleared embolic devices, independently from the study. The registry accesses data already documented during standard care, including headache diaries, clinical and procedural information, medication use, and outcomes. No additional procedures, interventions, or visits are required by the study team, and clinical decisions remain unaffected. Participants provide informed consent and continue regular clinical follow-up during which data is collected. Researchers analyze existing patient-reported outcome measures like headache diaries and HIT-6 scores to assess changes from baseline to 12 months. The study monitors safety through reported adverse events and does not involve extra assessments or interventions beyond usual care. Participation spans the routine clinical care period without additional study visits.
CONDITIONS
Brief Title
EMBRACE-OBS: Single-Site Observational Registry of Patient-Reported Outcomes Following MMA Embolization for Migraine
Research Team
D
Dennis Wang, Principal Investigator, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here